Management of patients with porphyria cutanea tarda. 1998

C Herrero, and M Lecha
Department of Dermatology, Faculty of Medicine, University of Barcelona, Spain.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017119 Porphyria Cutanea Tarda An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.

Related Publications

C Herrero, and M Lecha
July 1977, Cutis,
C Herrero, and M Lecha
May 2001, Clinical and experimental dermatology,
C Herrero, and M Lecha
September 1980, The Medical clinics of North America,
C Herrero, and M Lecha
January 1971, Sovetskaia meditsina,
C Herrero, and M Lecha
January 1998, Skin pharmacology and applied skin physiology,
C Herrero, and M Lecha
July 1976, The British journal of dermatology,
C Herrero, and M Lecha
September 1970, Archives of dermatology,
C Herrero, and M Lecha
January 1972, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
C Herrero, and M Lecha
May 1976, Nederlands tijdschrift voor geneeskunde,
C Herrero, and M Lecha
October 2001, Annales de dermatologie et de venereologie,
Copied contents to your clipboard!